These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30772137)

  • 1. Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma.
    Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Liu S
    Acad Radiol; 2019 Nov; 26(11):1473-1482. PubMed ID: 30772137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The primary lesion apparent diffusion coefficient is a prognostic factor for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.
    Huang TX; Lu N; Lian SS; Li H; Yin SH; Geng ZJ; Xie CM
    BMC Cancer; 2019 May; 19(1):470. PubMed ID: 31101029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
    BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
    Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
    Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
    Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
    Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of intravoxel incoherent motion model-based diffusion-weighted imaging for predicting long-term outcomes in nasopharyngeal carcinoma.
    Qin Y; Chen C; Chen H; Gao F
    Front Oncol; 2022; 12():902819. PubMed ID: 36531009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
    Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
    J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.
    Liang SB; Deng YM; Zhang N; Lu RL; Zhao H; Chen HY; Li SE; Liu DS; Chen Y
    BMC Cancer; 2013 May; 13():260. PubMed ID: 23710879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
    Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
    Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
    Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
    J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.
    Shi Q; Shen C; Kong L; Wang X; Ding J; Gao Y; Xu T; Hu C
    Radiat Oncol; 2014 Jan; 9():7. PubMed ID: 24393418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.
    Li YJ; Luo Y; Xie XQ; Li P; Wang F
    Radiother Oncol; 2018 Nov; 129(2):396-402. PubMed ID: 30082142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapy.
    Yang S; Lin S; Fu Q; Cai B; Kong F; Huang G; Li F; Wang H
    PLoS One; 2015; 10(3):e0120019. PubMed ID: 25799566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of failure in patients with nasopharyngeal cancer of Northeastern region of India: a retrospective observational study.
    Bhattacharyya M; Medhi PP; Sharma P; Nath J; Kalita AK; Roy PS; Rahman T; Yanthan Y
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3743-3753. PubMed ID: 38578506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.
    Wan XB; Wei L; Li H; Dong M; Lin Q; Ma XK; Huang PY; Wen JY; Li X; Chen J; Ruan DY; Lin ZX; Chen ZH; Liu Q; Wu XY; Hong MH
    Eur J Cancer; 2013 Jul; 49(10):2356-64. PubMed ID: 23541571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
    Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
    Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the tumor volume reduction rate after neoadjuvant chemotherapy in patients with locoregional advanced nasopharyngeal carcinoma.
    Yang H; Liu Y; Zhang R; Ye Y; Chen Q; Qin Q; Huang L; Li X; Cai R; Tang H; Jiang W
    Oral Oncol; 2020 Nov; 110():104897. PubMed ID: 32679404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
    Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.